CDC: Effectiveness of Moderna vaccine is staying especially strong. Latest COVID-19 updates
New research released by the Centers for Disease Control and Prevention on Friday shows that effectiveness of the Moderna vaccine is staying particularly strong.
Over the course of five months of research, from March to August, the effectiveness of all the vaccines at keeping people out of the hospital due to COVID among people without compromising conditions was highest for Moderna recipients, at 93%. Pfizer’s effectiveness was overall 88% and J&J’s was 71%.
Pfizer’s effectiveness decreased after 120 days of the study period, from 91% to 77%, while Moderna’s effectiveness did not see a similar decline. Initial effectiveness of 93% only declined to 92% with Moderna.
“Although these real-world data suggest some variation in levels of protection by vaccine, all FDA-approved or authorized COVID-19 vaccines provide substantial protection against COVID-19 hospitalization,” researchers concluded.
The report was released hours before an FDA committee decided not to recommend booster shots for people vaccinated with Pfizer, except in the case of the elderly and those with compromised immune systems.
📈Today’s numbers: The U.S. has recorded more than 41.9 million confirmed COVID-19 cases and more than 672,000 deaths, according to Johns Hopkins University data. Global totals: More than 227.7 million cases and 4.6 million deaths. More than 180.5 million Americans — 54.4% of the population — have been fully vaccinated, according to the Centers for Disease Control and Prevention.
📘What we’re reading: Opinion contributors Drs. Atul Grover and David J. Skorton say the nation’s badly flawed COVID response can be improved. Read the full piece.
Keep refreshing this page for the latest news. Want more? Sign up for USA TODAY’s Coronavirus Watch newsletter to receive updates directly to your inbox and join our Facebook group.
A nurse holds a syringe with the Pfizer-BioNTech COVID-19 vaccine at a vaccination clinic this week at the Reading Area Community College in Pennsylvania.
FDA panel recommends Pfizer boosters only for elderly, high-risk
After hours of discussion and a request to revise the question they were being asked, a key federal advisory committee on Friday recommended a third dose of the Pfizer-BioNTech COVID-19 vaccine six months after full vaccination for people aged 65 and older and those at high risk of severe COVID-19.
The initial question, posed by Pfizer, would have made the booster available to everyone aged 16 and up.
https://wakelet.com/wake/EFeRz340qDv1JY4KffJDd
https://wakelet.com/wake/qrtkfM3GKvaC58AqW6AUb
https://wakelet.com/wake/i-2a2VGb_JZbEN_1zi1Dw
https://wakelet.com/wake/nIGix3gftvPZEt9FbW28x
https://wakelet.com/wake/UqrDegXVeTt0ajTKf3TeK
https://wakelet.com/wake/ZcB1VB6BITlCm4VsBDwcB
https://wakelet.com/wake/JTENWVM7m9NHbbk9MZHQ6
https://wakelet.com/wake/g1AQN0rFst4HuvEY8TSDK
https://wakelet.com/wake/qKVIvjW10yrzQSZ_SoJsD
https://wakelet.com/wake/KHWN2FAkI2Q_Q5fOLXz2g
https://wakelet.com/wake/McRTjff53WSHvJQ9QYnHy
https://wakelet.com/wake/dm3DL2gKxqlJfXHZD9kjQ
https://wakelet.com/wake/uiI5Aq68h7mWdIzQAdVTd
https://altmetrics.org/author/Dearevan/
https://vocus.cc/article/61460d96fd89780001e4c866
https://vocus.cc/article/61460d98fd89780001e4c87c
https://vocus.cc/article/61460d9afd89780001e4c888
https://vocus.cc/article/61460d9cfd89780001e4c895
https://vocus.cc/article/61460d9dfd89780001e4c8a1
https://vocus.cc/article/61460d9ffd89780001e4c8ae
